�鶹��ýӰ��

Ian Ingram

Ian Ingram

Authors >

Ian Ingram

Ian Ingram joined MedPage Today in 2018 as Deputy Managing Editor, and covers oncology for the site. Ian Ingram has been a medical editor for the past decade. Prior to joining MedPage Today, he was managing editor of Cancer Network, directing the website’s news coverage and video production. Ian has also worked as a fact-checker, was an assistant editor at Narrative Magazine, and a manuscript reader at the Paris Review. He holds a B.A. in journalism from Purchase College. Ian lives in Connecticut, enjoys tennis, and almost always bowls a perfect game.

Connect:

email image

Latest from Ian Ingram

FDA APPROVED oral elafibranor (Iqirvo) over a computer rendering of a diseased liver.

Novel Drug for Rare Chronic Liver Disease Wins Conditional FDA Approval

First-in-class PPAR agonist led to biochemical responses in more than 50% of patients in trial

FDA APPROVED RSV prefusion F protein-based vaccine (Arexvy) over a microscope image of respiratory syncytial viruses.

FDA Expands Use of RSV Vaccine to Include More Adults

Arexvy now approved for people 50 years and older at increased risk of serious outcomes

ASCO over a photo of McCormick Place in Chicago, IL

Docetaxel Tied to Less Taxane Neuropathy in Black Breast Cancer Patients

Dose-limiting toxicity has been linked with worse outcomes specifically in this population

ASCO over a photo of McCormick Place in Chicago, IL

New Drug Effective for Tenosynovial Giant Cell Tumors, and With No Liver Concerns

Current option for rare tumor requires a REMS to monitor for drug-induced liver injury

ASCO over a photo of McCormick Place in Chicago, IL

Cheap Drug Eases Hot Flashes in Men With Prostate Cancer

Anticholinergic oxybutynin for patients taking ADT also improved quality of life in the process

ASCO over a photo of McCormick Place in Chicago, IL

Triplet Notches Survival Win in Heavily Pretreated DLBCL

Benefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant

ASCO over a photo of McCormick Place in Chicago, IL

'Practice Changing' Trial for Inoperable Locally Advanced NSCLC

EGFR testing now needed for all patients with stage III disease, experts say

ASCO over a photo of McCormick Place in Chicago, IL

Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents

China-based trial may present a hurdle to FDA approval, however

A photo of a pregnant woman holding a blisterpack of tablets.

Rare Pregnancy Problem Linked to Thiopurines, FDA Says

Agency finds risk for intrahepatic cholestasis of pregnancy mostly in IBD, lupus patients

A CT scan showing an abnormal mass in the liver.

Liver Cancer Screening Benefits Patients With Cirrhosis, Study Suggests

Analysis still finds improved survival after correcting for lead- and length-time biases

4

…